Physician profile
John K Weaver
NPI 1952523235
$3,498.19
in general payments reported to CMS, 2019-2025
8 companies · $744 in 2025
The $744 reported for 2025 was more than what 86% of Orthodontics and Dentofacial Orthopedics providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $294 · 2021: $295 · 2022: $897 · 2023: $160 · 2024: $1,108 · 2025: $744.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,470 · Consulting Fee: $509 · Education: $25.00 · Gift: $8.70.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,470.06 |
| Consulting Fee | $508.50 |
| Education | $25.00 |
| Gift | $8.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Align Technology, INC. | $2,421.66 | 2020-2025 | Invisalign, Invisalign Lens, Assembly Kit |
| Envista Holdings Corporation | $504.43 | 2024-2025 | Spark, Damon |
| Ultradent Products INC | $225.98 | 2021 | |
| Zimvie INC. | $120.89 | 2024 | |
| Ormco Corporation | $93.36 | 2022-2023 | Spark |
| Nobel Biocare USA | $77.86 | 2023 | Nobelactive |
| Zimmer Biomet Holdings, INC. | $37.31 | 2021 | |
| Dentsply Sirona INC | $16.70 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Weaver listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.